Cipher Pharmaceuticals Inc.
CPHRF
$12.00
-$0.56-4.46%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.79% | -4.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.79% | -4.10% | |||
| Cost of Revenue | -1.87% | -6.00% | |||
| Gross Profit | -5.45% | -3.66% | |||
| SG&A Expenses | -0.86% | -9.08% | |||
| Depreciation & Amortization | 0.50% | -0.55% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.85% | -6.33% | |||
| Operating Income | -11.02% | -0.34% | |||
| Income Before Tax | 8.34% | -33.52% | |||
| Income Tax Expenses | -599.76% | -342.77% | |||
| Earnings from Continuing Operations | 141.97% | -6.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 141.97% | -6.65% | |||
| EBIT | -11.02% | -0.34% | |||
| EBITDA | -12.11% | -0.43% | |||
| EPS Basic | 139.85% | -4.83% | |||
| Normalized Basic EPS | 16.13% | -34.26% | |||
| EPS Diluted | 140.95% | -4.55% | |||
| Normalized Diluted EPS | 16.50% | -34.17% | |||
| Average Basic Shares Outstanding | 0.88% | -1.91% | |||
| Average Diluted Shares Outstanding | 0.59% | -2.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||